OMI Urges Appeals Court to Allow Antitrust Challenge to Amgen’s Extension of Enbrel Monopoly

OMI Legal filed an amicus brief in the U.S. Court of Appeals for the Fourth Circuit urging the court to allow an antitrust lawsuit, CareFirst v. Amgen , that challenges Amgen’s use of acquired patent rights to extend its monopoly over the blockbuster drug Enbrel.